Literature DB >> 2566925

Down-regulation of 3H-lofentanil binding to opiate receptors in different cultured neuronal cells.

J M Maloteaux1, J N Octave, E C Laterre, P M Laduron.   

Abstract

There was stereospecific binding of 3H-lofentanil (KD value = 1.53 nM) to membranes of neuroblastoma-glioma NG 108-15 cells which are known to bear high affinity binding sites for enkephalin derivatives (delta-opiate receptor subtype). There was no high affinity specific binding of the mu-opiate specific ligand 3H-sufentanil. The specific binding of 3H-lofentanil to delta-opiate receptor subtype was down-regulated (decrease in Bmax value without change in the KD value) after prolonged incubation of the cells in the presence of leu- and met- enkephalin (0.1 microM). There was no down-regulation of the opiate receptors (3H-lofentanil and 3H-D-ala-D-leu-enkephalin specific binding) after incubation of NG 108-15 cells with drugs from the fentanyl series (alfentanil or sufentanil). In cultured neurones from rat forebrain (15 day old embryos), the 3H-lofentanil binding was specific with high affinity (KD: 0.048 nM) and a slow dissociation rate similar to that in adult rat cortex. Drugs of the fentanyl series (4-anilino-piperidines) were potent displacers whereas agonists of the delta- (enkephalin derivatives), sigma- (phencyclidine, haloperidol, 3-hydroxyphenyl-propylpiperidine) or K- (U 50488) opiate sites had a low affinity (Ki greater than 0.5 microM) for 3H-lofentanil specific binding sites. Since there was also specific binding of 3H-sufentanil, the opiate receptors in cultured neurones seem to be mainly of the mu-subtype and this is consistent with the ontogeny of opiate receptors subtypes. These receptors were down-regulated after incubation in the presence of etorphine, sufentanil and alfentanil but not enkephalin derivatives.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2566925     DOI: 10.1007/BF00165143

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  44 in total

1.  Receptor binding properties in vitro and in vivo of some long-acting opiates.

Authors:  J E Leysen; P M Laduron
Journal:  Arch Int Pharmacodyn Ther       Date:  1978-04

2.  Opiate binding to membrane preparations of neuroblastoma x glioma hybrid cells NG108-15: effects of ions and nucleotides.

Authors:  A J Blume
Journal:  Life Sci       Date:  1978-05-22       Impact factor: 5.037

Review 3.  Neurochemical correlates of opiate receptor regulation.

Authors:  R S Zukin; A Tempel
Journal:  Biochem Pharmacol       Date:  1986-05-15       Impact factor: 5.858

Review 4.  Phencyclidine and psychotomimetic sigma opiates: recent insights into their biochemical and physiological sites of action.

Authors:  M S Sonders; J F Keana; E Weber
Journal:  Trends Neurosci       Date:  1988-01       Impact factor: 13.837

5.  Up-regulation of opiate receptors by opiate antagonists in neuroblastoma-glioma cell culture: the possibility of interaction with guanosine triphosphate-binding proteins.

Authors:  J Barg; R Levy; R Simantov
Journal:  Neurosci Lett       Date:  1984-09-07       Impact factor: 3.046

6.  Down-regulation of delta but not mu opioid receptors in the hippocampal slice associated with loss of physiological response.

Authors:  R Dingledine; R J Valentino; E Bostock; M E King; K J Chang
Journal:  Life Sci       Date:  1983       Impact factor: 5.037

7.  The direction of opiodid agonists towards mu-, delta- and epsilon-receptors in the vas deferens of the mouse and the rat.

Authors:  M Wüster; R Schulz; A Herz
Journal:  Life Sci       Date:  1980-07-14       Impact factor: 5.037

8.  Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine.

Authors:  B L Largent; A L Gundlach; S H Snyder
Journal:  J Pharmacol Exp Ther       Date:  1986-08       Impact factor: 4.030

9.  Delta opioid receptors in human neuroblastoma cell lines.

Authors:  G Hochhaus; V C Yu; W Sadée
Journal:  Brain Res       Date:  1986-09-24       Impact factor: 3.252

10.  [3H]Sufentanil, a superior ligand for mu-opiate receptors: binding properties and regional distribution in rat brain and spinal cord.

Authors:  J E Leysen; W Gommeren; C J Niemegeers
Journal:  Eur J Pharmacol       Date:  1983-02-18       Impact factor: 4.432

View more
  1 in total

1.  HINT1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate NMDA receptor activity.

Authors:  Ana Vicente-Sánchez; Pilar Sánchez-Blázquez; María Rodríguez-Muñoz; Javier Garzón
Journal:  Mol Brain       Date:  2013-10-05       Impact factor: 4.041

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.